Mucosal SARS-CoV-2 S1 Adenovirus-Based Vaccine Elicits Robust Systemic and Mucosal Immunity and Protects Against Disease in Animals.
Najwa D. Aljehani,Levi Tamming,Muhammad Yasir Khan,Rwaa H. Abdulal,Mohamed A. Alfaleh, Aishah Ghazwani, Asalah Helal,Reem M. Alsulaiman,Mohammad A. Sanki, Khalid Alluhaybi, Farah Ayman Sukareh,Rahaf H. Alharbi, Faris H. Alyami, M-Zaki ElAssouli, Salima Shebbo,Wesam H. Abdulaal,Abdullah Algaissi,Ahmad Bakur Mahmoud,Mohammad Basabrain,Diana Duque,Jegarubee Bavananthasivam,Wangxue Chen, Lisheng Wang,Simon Sauve,Turki S. Abujamel,Tarfa Altorki,Rowa Alhabbab,Anh Tran,Xuguang Li,Anwar M. Hashem MBIO（2025）
Key words
vaccine,SARS-CoV-2,mucosal vaccines,adenoviruses
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper